glp-1 news today oct 2 2025 RA prescription trends: January 2018 – September GLP-1 Drugs: 2025 Pulse Survey

In some clinical trials, patients who received Semaglutide GLP-1 lost an average of 14.9% of their body weight over 68 weeks and experienced a reduction in waist circumference and visceral adipose tissue

Results usually improve when medication is paired with consistent nutrition, sleep, and exercise habits

What I learned from the conference was that theres still so much we dont know about GLP-1s and performance

Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: the impact GLP-1 CKD study